VEGFA and cancer: Given the cytostatic/non-cytotoxic action of metronomic treatment interfering with cancer neo-angiogenesis processes [7] we can suppose that in responder patients study treatment can effectively stop tumor growth by limiting neo-angiogenesis and so we do not observe any VEGF level increase.